Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in CAD Patients Treated with PCI
NCT06095765Phase 3Recruiting
- Sponsor
- AZ Sint-Jan Brugge
- Start
- Jan 2024
- Primary completion
- Nov 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in coronary artery disease (CAD), sponsored by AZ Sint-Jan Brugge. Started Jan 2024; status: recruiting.
02
Drugs
colchicine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT06095765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06095765.